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The aim of this study was to obtain a better understanding of the role of hormonal factors in breast cancer risk and to
determine whether the effect of reproductive events differs according to age at diagnosis. It analysed the effect of age at
menarche, age at ﬁrst full-term pregnancy, number of full-term pregnancies and number of spontaneous abortions both on the
overall risk of breast cancer and on its pre- or postmenopausal onset, using the data on 1718 breast cancer cases, obtained
from a large sample of around 100000 French women participating in the E3N cohort study. The results provide further
evidence that the overall risk of breast cancer increases with decreasing age at menarche, increasing age at ﬁrst pregnancy and
low parity. No overall effect of spontaneous abortions was observed. The effect of these reproductive factors differed
according to menopausal status. Age at menarche had an effect on premenopausal breast cancer risk, with a decrease in risk
with increasing age of 7% per year (P50.05). Compared to those who had their ﬁrst menstrual periods at 11 or before,
women experiencing menarche at 15 or after had an RR of 0.66 (95% CI 0.45–0.97) in the premenopausal group. Age at
ﬁrst full-term pregnancy had an effect on both pre- and postmenopausal breast cancer risk, with signiﬁcant tests showing
increasing risk per year of increasing age (P=0.001 and P50.05 respectively). A ﬁrst full-term pregnancy above age 30
conveyed a risk of 1.63 (95% CI 1.12–2.38) and 1.35 (95% CI 1.02–1.78) in the pre- and postmenopausal groups
respectively. A protective effect of high parity was observed only for postmenopausal breast cancer risk (P for trend test
=0.001), with point estimates of 0.79 (95% CI 0.60–1.04), 0.69 (95% CI 0.54–0.88), 0.66 (95% CI 0.51–0.85) and 0.64 (95%
CI 0.48–0.86) associated to a one, two, three and four or more full-term pregnancies. A history of spontaneous abortion had
no signiﬁcant effect on the risk of breast cancer diagnosed before or after menopause. Our results suggest that reproductive
events have complex effects on the risk of breast cancer.
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There is a considerable body of evidence that reproductive factors
play a role in the aetiology of breast cancer risk (Kelsey et al, 1993).
However, the biological mechanism is not yet clearly understood.
Results showing the effect of these factors by age or menopausal
status at the time of diagnosis may help to give a better under-
standing of their role.
A pooled analysis of the literature showed that early age at
menarche and late age at ﬁrst full-term pregnancy (FFTP) had a
greater effect on the risk of breast cancers diagnosed early (i.e. at
an early age or before menopause) than on the risk of those diag-
nosed late (i.e. after 55 or after menopause). In contrast, it has
been shown that the protective effect of multiparity is greater on
late breast cancers (Clavel-Chapelon and Gerber, 2001). Epidemio-
logical studies reporting on the relationship between breast cancer
risk and spontaneous or induced abortions by age have produced
conﬂicting results (Michels and Willett, 1996; Wingo et al, 1997).
We report here on the effects of age at menarche, age at FFTP,
number of full-term pregnancies (FTP) and number of sponta-
neous abortions both on the overall risk of breast cancer and on
its pre- or postmenopausal onset, using data obtained from a large
sample of French women participating in the E3N cohort study.
MATERIALS AND METHODS
E3N is a prospective cohort study on cancer risk factors, conducted
in France (Clavel-Chapelon, 1997). Part of the E3N cohort, i.e.
women who replied to the dietary questionnaire, are included in
the European Prospective Investigation on Cancer (EPIC) (Riboli,
1992).
The cohort consists of 100000 women living in France who are
insured with the Mutuelle Ge ￿ne ￿rale de l’Education Nationale, a
national health insurance scheme primarily covering teachers.
They were aged 40–65 at baseline. The main objective of the
study was to investigate risk factors for cancer and other diseases
(cardiovascular diseases, diabetes and osteoporosis). Participants
were enrolled in the study between June 1990 and November
1991 after replying to a baseline questionnaire containing ques-
tions on lifestyle, i.e. reproductive factors, body build, smoking,
past medical history and family history of cancer. Follow-up ques-
tionnaires were sent out at approximately 24-month intervals until
April 1997.
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abortions and number of FTP were recorded in the two ﬁrst ques-
tionnaires. Menopausal status was recorded in each questionnaire.
Postmenopause was deﬁned as the cessation of periods for natural
reasons or due to surgery (total oophorectomy). Women with
undeﬁned menopausal status (for instance due to continuous use
of hormonal treatments, or hysterectomy with no additional infor-
mation on oophorectomy) were considered in the premenopausal
group up to 42 years of age, and in the postmenopausal one after
58. They were not considered in the analysis by subgroup between
these limits (i.e. (42–58) years of age, deﬁned as the mean age at
menopause in our population +2 s.d.), as were women who never
menstruated.
All questionnaires asked participants whether breast cancer had
been diagnosed, requesting the addresses of their physicians and
permission to contact them. Deaths in the cohort were detected
from reports by family members or by the postal service and by
a search on the insurance company (MGEN) ﬁle, which contains
information on vital status. Information on the cause of death
was obtained from the National Service on Causes of Deaths
(INSERM). Information on non-respondents was obtained from
the MGEN ﬁle on reimbursement of hospital fees. In this case,
the subject’s physician was contacted for diagnostic information.
The procedure made it possible to ﬁnd additional breast cancer
cases (n=39). Only 1815 women could not be traced in the MGEN
ﬁle (names misspelled, names changed after divorce, no longer
insured with the MGEN, etc.). Among these, non respondents were
considered lost to follow-up.
Follow-up time was between return of the baseline questionnaire
and December 1997, the date by which most copies (92%) of the
ﬁfth questionnaire (sent out in April 1997) had been returned.
Participants contributed person-time up to the date of any diagno-
sis of breast cancer, date of death, date of last questionnaire
returned or December 1997 (for replies to the April 1997 question-
naire received after December 1997), whichever occurred ﬁrst.
Women whose menopause occurred during the period of follow-
up contributed person-time in the premenopausal group until the
date of menopause and in the postmenopausal group thereafter.
A total of 2100 breast cancer cases were reported by participants.
Pathology reports were obtained for 97% (n=2044) of cases. Of
these, 94.5% conﬁrmed the self-reported diagnosis of breast cancer.
After exclusion of the 112 cases whose diagnosis was rejected as a
result of the pathology report and 270 cases of carcinoma in situ,
1718 cases of invasive breast cancer were available for analysis,
including the 56 cases whose diagnosis was based on the self-report
only, as self-reporting proved to be extremely accurate. Histologic
types were coded by a pathologist blinded to data on risk factors.
Women who had reported a cancer other than a basal cell carci-
noma at enrolment were excluded.
Statistical analyses were performed using SAS statistical software.
A proportional hazard model with follow-up time as the time axis
was used (Cox, 1972) allowing estimation of relative risks (RRs)
and 95% conﬁdence intervals. All reproductive factors were
included simultaneously in the model to adjust for mutual
confounding, since the four reproductive factors studied may inﬂu-
ence each other. We also took into account as potential
confounders age, personal history of benign breast disease, familial
history of breast cancer, body mass index, marital status and
educational level, because of their possible association with charac-
teristics of the reproductive life and with breast cancer. Analyses
were performed on the whole cohort, and further stratiﬁed by
menopausal status.
Indeed, the whole population was split into three categories:
premenopausal, postmenopausal and of unknown menopausal
status. However, the vast majority of breast cancer cases were able
to date their menopause from the date of radio- or chemotherapy.
As a consequence, in that third category, the incidence rate was low
and results are not presented here.
RESULTS
Table 1 shows the distribution of all survey participants by age,
education, cohabitation and menopausal status at baseline, and
in separate strata of menopausal status. Among the 91260 partici-
pants, 39148 were premenopausal and 50996 postmenopausal at
the end of follow-up; menopause occurred during the follow-up
for 16026; for 17138, menopausal status could not be deﬁned; four
never menstruated. A total of 1718 cases of invasive breast cancer
were diagnosed in the 579525 person–years of follow-up. Four
hundred and seventy-eight cases occurred before menopause,
1057 after and 183 with undeﬁned menopausal status were not
considered in the analysis by subgroup.
Menstrual and reproductive factors are considered in Table 2.
A 3% decrease in breast cancer risk was found for each addi-
tional year at menarche (RR=0.97, 95% CI 0.93–0.99;
P50.05). Breast cancer risk increased with increasing age at
FFTP by 3% per year (RR=1.03, 95% CI 1.01–1.04; P510
74,
among the 1447 parous women). Each FTP reduced the risk
by 8% (RR=0.92, 95% CI 0.88–0.96; P510
74). All estimates
of the relationship between breast cancer risk and spontaneous
abortions were non-signiﬁcant.
Table 3 shows the results according to menopausal status. The
effect of age at menarche was similar in both subgroups. For each
additional year in age at menarche, breast cancer risk decreased by
7% (RR=0.93, 95% CI 0.87–0.99; P50.05) for breast cancers diag-
nosed before menopause and by 3% (RR=0.97, 95% CI 0.93–1.01)
for those diagnosed later. An increase in age at FFTP increased the
risk by 4% (RR=1.04, 95% CI 1.02–1.06; P=0.001) per year for
breast cancer diagnosed in premenopausal women and by 2%
(RR=1.02, 95% CI 1.00–1.04; P50.05) per year for breast cancer
diagnosed in postmenopausal women. The protective effect of an
increasing number of FTPs was apparent only among postmeno-
pausal women (RR=0.91, 95% CI 0.86–0.96; P50.001). A
history of spontaneous abortion had no signiﬁcant effect on the
risk of breast cancer diagnosed before or after menopause.
DISCUSSION
The results provide further evidence that the overall risk of breast
cancer increases with decreasing age at menarche, increasing age at
ﬁrst pregnancy and low parity. No overall effect of spontaneous
abortions was observed. However, the effect of these reproductive
factors differed according to menopausal status. Age at menarche
had a signiﬁcant effect on premenopausal breast cancer risk. Age
at FFTP had a signiﬁcant effect on the risk in both subgroups,
the effect being slightly greater before menopause. Parity had a
signiﬁcant protective effect in the postmenopausal subgroup. A
history of spontaneous abortions had no effect on the risk.
Consideration must be given to the validity of the data on
reproductive factors. In a substudy of 751 women in the E3N study
who completed the same self-administered questionnaire twice, we
found a high rate of reproducibility for answers on age at
menarche, age at ﬁrst pregnancy, number of live births and dura-
tion of ﬁrst pregnancy, with 71, 64, 98 and 80% respectively of
identical answers. Nevertheless, even if assessment problems cannot
be excluded, there should be no difference between cases and non-
cases, given the prospective nature of the study. The reliability of
the menopausal status and of age at menopause was assessed in
a validation study (Clavel-Chapelon and Dormoy-Mortier, 1998).
Agreement between the answer given in the initial questionnaire
and the information collected from medical records of 151 women
revealed a high concordance between the two sources (Kappa coef-
ﬁcient=0.85). Moreover, in the present study, women were
categorised according to their menopausal status, after taking into
account simultaneously, to correct for possible incoherences, all
answers to the question on menopause, asked in the initial and
all subsequent questionnaires.
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ture (Clavel-Chapelon and Gerber, 2001), though both chance and
a lack of power may explain them.
On 21 studies, we showed that breast cancer risk decreased by
about 9% (95% CI 7–11%) for each additional year in age at
menarche for breast cancers diagnosed early or before menopause
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Table 1 Selected characteristics of the population at inclusion
All women Premenopausal Postmenopausal
(n=91260) (n=39148) (n=50996)
Characteristics at inclusion % n % n % n
Age (years)
40–45 34.7 31 650 59.2 23 172 8.8 4474
45–50 24.4 22 242 30.5 11 933 22.0 11 238
50–55 19.3 17 664 9.6 3734 30.7 15 673
55–60 13.0 11 835 0.7 284 23.1 11 756
60–65 8.6 7855 0.0 13 15.4 7853
Not stated 0 14 0.0 12 0 2
Number of years of education
57 4.9 4433 3.0 1180 6.3 3230
7–11 8.4 7687 7.3 2853 9.4 4793
12–14 47.1 42 986 45.8 17 925 49.2 25 067
15–16 17.4 15 926 21.6 8460 13.6 6932
17+ 16.8 15 329 17.6 6880 16.2 8266
Not stated 5.4 4899 4.7 1850 5.3 2708
Cohabitation status
Not living with a partner 17.4 15 871 16.0 6276 18.9 9656
Living with a partner 77.2 70 482 79.5 31 128 75.7 38 571
Not stated 5.4 4907 4.5 1744 5.4 2769
Table 2 Reproductive factors and breast cancer risk. E3N-EPIC cohort study, 1990–1997
All women
No of Person–years of Multivariate* RR
Characteristic cases follow-up (95% CI)
Age of menarche (years)
512 379 118 702 1.00
12 443 143 921 0.97 (0.85–1.11)
13
f 441 153 419 0.91 (0.79–1.04)
14 305 108 277 0.89 (0.77–1.04)
15+ 150 55 206 0.84 (0.70–1.02)
Trend* 0.97 (0.93–0.99)
a
Age at FFTP (among parous) (years)
522 232 94 468 1.00
22–24 461 171 850 1.07 (0.91–1.25)
25–27 382 129 234 1.16 (0.98–1.38)
28–30 201 62 741 1.25 (1.03–1.52)
31+ 171 45 500 1.46 (1.18–1.81)
Trend
d 1.03 (1.01–1.04)
b
Number FTP
0
f 271 75 732 1.00
1 295 92 361 0.76 (0.61–0.95)
2 705 245 718 0.73 (0.60–0.89)
3 326 121 610 0.68 (0.55–0.83)
4+ 121 44 104 0.68 (0.53–0.87)
Trend
d 0.92 (0.88–0.96)
b
Number of spontaneous abortions
0 pregnancy 218 59 626 1.26 (1.02–1.55)
0 spontaneous abortion
f 1115 387 832 1.00
1 278 96 407 0.99 (0.87–1.13)
2 72 25 187 0.97 (0.76–1.23)
3+ 35 10 473 1.13 (0.80–1.58)
Trend
d,e 1.01 (0.95–1.09)
aP50.05;
bP50.0001;
cadjusted for the other three characteristics studied and for age (40–44, 45–49, 50–54, 55–59, 60+),
history of benign breast disease (Y/N), ﬁrst or second degree relative with breast cancer (Y/N), current body mass index
(continuous variable), if ever married (Y/N) and educational level (ﬁve categories);
dcontinuous variable;
ein women with at
least one pregnancy;
fincluding missing values (age at menarche: 18 breast cancer cases, 1799 person–years; age at FFTP:
two breast cancer cases, 294 person–years; number of FTP: 20 breast cancer cases, 1749 person–years; number of sponta-
neous abortions: 0 breast cancer cases, 235 person–years).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(5), 723–727and by about 4% (95% CI 2–5%) for those diagnosed later. The
hormonal levels to which girls are exposed increase continuously
with age until menarche (Forrest and Bertrand, 1997) and it has
been hypothesised that early menarche induces an early prolifera-
tion of breast cells through early exposure to high hormonal
levels. However, a decrease in age at menarche has been described
in many countries throughout the world. In our cohort, age at
menarche decreased by 6 months over a period of 20 years, from
13.3 to 12.7 on average for the 1930 and 1950 birth cohorts respec-
tively. This evolution is possibly due to several factors; for instance
changes in food intake or in physical activity, which induce other
hormonal changes in young girls, and may subsequently affect the
breast cancer risk (Stoll, 1998).
In our previous analysis of 18 studies on age at FFTP, we found
that each additional year led to an increased risk of 1.05 for early
breast cancer and 1.03 for late breast cancer. According to the
proposed multi-step process of carcinogenesis (Ponten et al,
1990), i.e. initiation, promotion, tumour and progression, undiffer-
entiated cells, which have not undergone the maturation process,
may be initiated by carcinogens and after promotion give rise to
a breast tumour several years later. The differentiation of breast
cells that occurs during the third trimester of pregnancy makes
them less sensitive, or insensitive, to initiating agents. In other
words the earlier the FFTP, the earlier the cells undergo differentia-
tion. The proliferation of breast cells, which is greatest between 10
and 20 years of age, facilitates the promotion of the carcinogenic
process.
Our previous review concluded that the relationship
between breast cancer and parity, which had been investigated
in 20 studies, resulted in a 3% (95% CI 1–6%) reduction in
the risk of breast cancer diagnosed early or before menopause
for each FTP, whereas the reduction rose to 12% (95% CI
10–14%) for breast cancers diagnosed later. The protective
effect of multiparity is thus greater for cancers emerging late
in life, and this agrees with recent studies that have found a
transient increase in breast cancer risk immediately after each
pregnancy (Lambe et al, 1994; Leon et al, 1995; Chie et al,
2000). The effect of multiparity might therefore derive from
a short-term increase in risk followed by a long-term protec-
tive effect against late cancers. It could also be argued that
the protective effect of multiparity may not be observed
among young women simply because they are not usually
multiparous.
Recent reviews on the relationship between breast cancer and
spontaneous abortion (Michels and Willett, 1996; Wingo et al,
1997) did not come to any deﬁnitive conclusions, irrespective of
whether study participants were under or over 45 years of age
(Wingo et al, 1997).
Spontaneous abortions result in the lack of differentiation of
the breast cells that occurs at the end of FTP. Spontaneous abor-
tions that result from abnormally low production of progesterone
by the corpus luteum may affect breast cancer risk as a conse-
quence of low progesterone production. Whether the indication
of a transient protection observed in our study on early breast
cancer risk is due to the abrogation of the transient increase
attributed to the ﬁnal months of pregnancy, or is linked to the
hormonal milieu, or is merely attributable to chance requires
further investigation.
E
p
i
d
e
m
i
o
l
o
g
y
Table 3 Reproductive factors and risk of pre- and postmenopausal breast cancer. E3N–EPIC cohort study, 1990–1997
Premenopausal women Postmenopausal women
No of Person–years of Multivariate RR No of Years–years of Multivariate RR
Characteristic cases follow-up
d (95% CI) cases follow-up
d (95% CI)
Age at menarche (years)
512 121 32 139 1.00 228 55 036 1.00
12 106 39 533 0.71 (0.54–0.92) 280 67 316 1.02 (0.85–1.21)
13 135 41 732 0.84 (0.66–1.08) 253 72 688 0.86 (0.71–1.03)
14 81 28 708 0.72 (0.54–0.96) 197 53 803 0.93 (0.77–1.13)
15+ 35 13 094 0.66 (0.45–0.97) 99 30 650 0.84 (0.66–1.07)
Trend 0.93 (0.87–0.99)
a 0.97 (0.93–1.01)
Age at FFTP (among parous) (years)
522 67 25 216 1.00 137 43 229 1.00
22–24 118 45 070 0.97 (0.71–1.31) 295 83 005 1.11 (0.90–1.36)
25–27 110 34 358 1.21 (0.89–1.65) 228 62 617 1.12 (0.90–1.40)
28–30 68 17 748 1.48 (1.04–2.10) 115 30 083 1.14 (0.88–1.48)
31+ 57 14 262 1.63 (1.12–2.38) 98 20 962 1.35 (1.02–1.78)
Trend
d 1.04 (1.02–1.06)
b 1.02 (1.00–1.04)
a
Number FTP
0 58 18 552 1.00 184 39 597 1.00
1 80 26 283 0.77 (0.50–1.19) 184 42 798 0.79 (0.60–1.04)
2 232 72 267 0.91 (0.62–1.34) 386 104 843 0.69 (0.54–0.88)
3 86 30 513 0.84 (0.56–1.27) 209 62 400 0.66 (0.51–0.85)
4+ 22 7591 0.88 (0.51–1.52) 94 29 855 0.64 (0.48–0.86)
Trend
d 0.98 (0.89–1.07) 0.91 (0.86–0.96)
b
Number of spontaneous abortions
0 pregnancy 47 13 970 1.35 (0.89–2.06) 146 32 005 1.17 (0.90–1.51)
0 spontaneous abortion 337 105 983 1.00 656 182 450 1.00
1 72 26 175 0.85 (0.66–1.10) 181 46 710 1.09 (0.92–1.28)
2 15 6487 0.70 (0.42–1.18) 48 12 916 1.03 (0.77–1.39)
3+ 7 2591 0.83 (0.39–1.76) 26 5412 1.31 (0.89–1.95)
Trend
d,e 0.90 (0.77–1.04) 1.06 (0.98–1.15)
aP50.05;
bP=0.001;
cadjusted for the other three characteristics studied and for age (40–44, 45–49, 50–54, 55–59, 60+), history of benign breast disease (Y/N), ﬁrst or
second degree relative with breast cancer (Y/N), current body mass index (continuous variable), if ever married (Y/N) and educational level (ﬁve categories); in postmenopausal
women, also adjusted for age (540, 41–50, 51+) and type of menopause (natural, artiﬁcial, other);
dcontinuous variable;
ein women with at least one pregnancy;
fPerson–years
before menopause included in premenopausal subgroup, person–years after menopause included in postmenopausal subgroup.
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